Proto Labs, Inc.
PRLB
$50.86
$0.080.16%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 518.38M | 508.64M | 499.21M | 500.89M | 504.19M |
| Total Other Revenue | -- | 281.00K | 390.00K | 550.00K | 806.00K |
| Total Revenue | 518.38M | 508.64M | 499.21M | 500.89M | 504.19M |
| Cost of Revenue | 289.66M | 283.98M | 277.77M | 277.69M | 277.13M |
| Gross Profit | 228.72M | 224.66M | 221.43M | 223.20M | 227.06M |
| SG&A Expenses | 163.99M | 161.13M | 157.53M | 156.41M | 156.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 495.83M | 486.36M | 476.04M | 475.39M | 474.36M |
| Operating Income | 22.55M | 22.28M | 23.16M | 25.50M | 29.83M |
| Income Before Tax | 22.63M | 22.25M | 22.93M | 24.67M | 34.89M |
| Income Tax Expenses | 7.79M | 7.43M | 8.01M | 8.08M | 10.91M |
| Earnings from Continuing Operations | 14.84 | 14.81 | 14.92 | 16.59 | 23.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.84M | 14.81M | 14.92M | 16.59M | 23.99M |
| EBIT | 22.55M | 22.28M | 23.16M | 25.50M | 29.83M |
| EBITDA | 57.40M | 57.61M | 58.89M | 61.63M | 66.86M |
| EPS Basic | 0.62 | 0.61 | 0.60 | 0.66 | 0.94 |
| Normalized Basic EPS | 0.74 | 0.71 | 0.72 | 0.75 | 0.95 |
| EPS Diluted | 0.61 | 0.60 | 0.60 | 0.65 | 0.94 |
| Normalized Diluted EPS | 0.73 | 0.71 | 0.72 | 0.75 | 0.95 |
| Average Basic Shares Outstanding | 96.40M | 97.49M | 98.90M | 100.39M | 101.74M |
| Average Diluted Shares Outstanding | 97.20M | 98.03M | 99.31M | 100.65M | 102.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |